TERIFLUNOMIDE
| Brand name | AUBAGIO |
|---|---|
| Active ingredient | TERIFLUNOMIDE |
| Strength | 7MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9186346*PED | August 2034 | — |
| 9186346 | February 2034 | use U-1786 |
| 8802735*PED | March 2031 | — |
| 8802735 | September 2030 | product |
| 6794410*PED | March 2027 | — |
| 6794410 | September 2026 | use U-1285 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.